Swiss National Bank and DekaBank increased their stakes in AstraZeneca shares on July 29, 2026.
1 report, 1 independent
Updated Jul 29
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Swiss National Bank and DekaBank increased their stakes in AstraZeneca shares on July 29, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Swiss National Bank
central bank of Switzerland
-
AstraZeneca
British-Swedish pharmaceutical company
Related events
- The Swiss National Bank and Swedbank AB boosted their respective stakes in companies.
- AstraZeneca listed shares on the New York Stock Exchange to attract investors.
- Swiss National Bank raised its position in NCR Atleos Corporation, accompanied by a filing with the Securities and Exchange Commission.
- Swiss National Bank and Amundi lifted their holdings in Alphabet Inc. shares on October 23, 2026.